No Picture
News

Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding Company

SAN DIEGO, Sept. 22, 2023 /PRNewswire/ — Sorrento Therapeutics, Inc. (OTC: SRNEQ, “Sorrento” or “Company”), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, intractable pain, and infectious disease, announced the […]

News

Ligand’s Partner Jazz Pharmaceuticals Receives European Commission Approval for Enrylaze® (a recombinant Erwinia asparaginase or crisantaspase) for the Treatment of Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

SAN DIEGO–(BUSINESS WIRE)–Ligand’s Partner Jazz Pharmaceuticals Receives European Commission Approval for Enrylaze Click here to view original post

No Picture
News

Monoceros Biosystems and SeekIn Join Forces to Pave the Way for Cutting-Edge AI-Powered Cancer Diagnostics

SAN DIEGO, Sept. 21, 2023 /PRNewswire/ — Monoceros Biosystems, a prominent bioinformatics service provider in the United States, is thrilled to announce a strategic partnership with SeekIn, a leading liquid biopsy testing provider in China, […]

News

Enrollment Completed in the Feasibility Phase of the FORESEE Clinical Trial with Biocept’s CNSide™ Assay to Evaluate Patients with Leptomeningeal Metastases

SAN DIEGO–(BUSINESS WIRE)—- $BIOC #CSF–Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces the full enrollment of 40 subjects with breast or non-small cell lung cancer (NSCLC) who have […]

News

Exclusive: AstraZeneca signs off on a ‘carbon negative’ new biotech building for one of its latest buyouts

Breakthrough Properties is back keeping the dirt flying in biotech — this time breaking new ground in Amsterdam. The commercial real estate alliance between Tishman Speyer, which built Pfizer’s new world headquarters in Manhattan, and […]

News

Oxford Nanopore moves into mRNA vaccine testing as researchers report faster quality control process

Researchers at the University of Queensland say they’ve developed a faster way to put mRNA vaccines through quality control testing, according to a study published today in Nature Communications. Oxford Nanopore, the company whose technology […]

News

Equillium to Present at the Cantor Fitzgerald Global Healthcare & LD Micro Main Event Conferences

LA JOLLA, Calif.–(BUSINESS WIRE)—- $EQ–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that it will present at the Cantor Fitzgerald Global […]

No Picture
News

HILLHURST BIOPHARMACEUTICALS RECEIVES $3 MILLION IN NIH SBIR FUNDING FOR PHASE 2A CLINICAL STUDY IN SICKLE CELL DISEASE

SAN DIEGO, Sept. 20, 2023 /PRNewswire/ — Hillhurst Biopharmaceuticals, Inc. (“Hillhurst”), a clinical-stage biopharmaceutical company focused on developing liquid drug products containing therapeutic gases, today announced the award of an approximately $3 million Phase 2b […]

No Picture
News

Regulus Therapeutics Announces Positive Topline Data from the First Cohort of Patients in its Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Statistically significant increase in urinary polycystin 1(PC1) after treatment with RGLS8429 Urinary polycystin exhibits anticipated pharmacokinetics/pharmacodynamics (PK/PD) correlation in patients with ADPKD Company to hold conference call at 8:30 a.m. EDT today SAN DIEGO, Sept. […]

News

Longboard Pharmaceuticals to Host Investor & Analyst Event in New York on October 11, 2023

LA JOLLA, Calif.–(BUSINESS WIRE)—- $LBPH #Epilepsy–Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that it will host an Investor & Analyst Event focused […]

News

Acadia Pharmaceuticals Appoints Albert Kildani as Senior Vice President, Investor Relations and Corporate Communications

SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the appointment of Albert Kildani as Senior Vice President, Investor Relations and Corporate Communications. Mr. Kildani will be responsible for leading investor relations and corporate communications […]